According to a recent LinkedIn post from BVI Medical, the company is highlighting its glaucoma portfolio aimed at supporting Minimally Invasive Glaucoma Surgery, or MIGS, with a focus on reducing aqueous in-flow to lower intraocular pressure. The post points to a range of laser and endoscopy solutions designed to address diverse surgical needs in glaucoma care.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post also notes that BVI Medical plans to be present at the EGS Congress in Brussels from May 30 to June 2 at Booth 16, positioning the event as a venue to learn more about its glaucoma solutions and directing viewers to an external link for additional information. This visibility at a specialized ophthalmology congress may support commercial outreach, reinforce relationships with eye surgeons, and potentially drive incremental adoption of its glaucoma technologies over time, although product availability and approvals may differ by market.